References
- Ananth CV, Vintzileos AM. Epidemiology of preterm birth and its clinical subtypes. J Matern Fetal Neonatal Med. 2006 Dec;19(12):773–82.
- National Center for Health Statistics. Natl Vital Stat Rep. 2010 Dec 3;59(2):1–72.
- Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2011. Natl Vital Stat Rep. 2012 Oct;61(5):1–18.
- Canada S. Discharge Abstract Database. Canadian Institute for Health Information and Can Vital Stat Syst. 2006 Aug 4.
- Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010 Jan;88(1):31–8.
- Modanlou HD, Dorchester WL, Thorosian A, Freeman RK. Antenatal versus neonatal transport to a regional perinatal center: a comparison between matched pairs. Obstet Gynecol. 1979 Jun;53(6):725–9.
- Kollée LA, Verloove-Vanhorick PP, Verwey RA, Brand R, Ruys JH. Maternal and neonatal transport: results of a national collaborative survey of preterm and very low birth weight infants in The Netherlands. Obstet Gynecol. 1988 Nov;72(5):729–32.
- Van Hook JW, Leicht TG, Van Hook CL, Dick PL, Hankins GD, Harvey CJ. Aeromedical transfer of preterm labor patients. Tex Med. 1998 Nov 1;94(11):88–90.
- Wilson AK, Martel M-J. Maternal transport policy. J Obstet Gynaecol Can. 2005 Oct 28;27(10):956–8.
- Jony L, Baskett TF. Emergency air transport of obstetric patients. J Obstet Gynaecol Can. 2007 May;29(5):406–8.
- Duley L, Bennett P. Tocolysis for Women in Preterm Labour: Green-top Guideline No. 1b. R Coll Obstet Gynaecol. 2011 Jul 26;1–13.
- FDA DSC. New warnings against use of terbutaline to treat pre-term labour [Internet]. www.fda.gov. Wiley; 2007 [cited 2013 Aug 4]. Available from: www.fda.gov /Drugs/Drug Safety/ucm243539.htm#ds
- Smith GN. What are the realistic expectations of tocolytics? BJOG. 2003 Apr;110(s20):103–6.
- Lauersen NH. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med. 1992 Dec 10;327(24):1759–60.
- Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille J-C, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol. 2000;182(5):1173–83.
- King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev. 2005;(2):1–77.
- King JF, Flenady V, Papatsonis D, Dekker G, Carbonne B. Calcium channel blockers for inhibiting preterm labour. In: Flenady V, ed. Cochrane Database Systematic Review. Wiley; 2011 Sep 1 (2):1–73.
- Hayes E, Moroz L, Pizzi L, Baxter J. A cost decision analysis of 4 tocolytic drugs. Am J Obstet Gynecol. 2007 Oct;197(4):383.e1–383.e6.
- Papatsonis D, Flenady V, Cole S, Liley H. Oxytocin receptor antagonists for inhibiting preterm labour. In: Papatsonis D, ed. Cochrane Database Systematic Review. Wiley; 2010 Sep 1 (1):1–53.
- Duckitt K, Thornton S. Nitric oxide donors for the treatment of preterm labour. Cochrane Database Syst Rev. 2011 (11):1–32.
- Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. In: Crowther CA, ed. Cochrane Database Systematic Review. Wiley; 2009 Sep 1 (4):CD001060.
- Anotayanonth S, Subhedar NV, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. In: Anotayanonth S, ed. Cochrane Database Systematic Review. Chichester, UK: Wiley; 2010 Sep 1 (2):1–79.
- de Heus R, Mol BW, Erwich J-JH, van Geijn HP, Gyselaers WJ, Hanssens M, et al. Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. Br Med J. 2009;338.
- Freda MC, DeVore N. Should intravenous hydration be the first line of defence with threatened preterm labor –a critical review of the literature. J Perinatol. 2006 Aug 3;16(5):385–9.
- McGregor JA, French JI, Witkin S. Infection and prematurity: evidence-based approaches. Curr Opin Obstet Gynecol. 1996 Dec;8(6):428–32.
- Yudin MH, van Schalkwyk J, Van Eyk N, Boucher M, Castillo E, Cormier B, et al. Antibiotic therapy in preterm premature rupture of the membranes. J Obstet Gynaecol Can. 2009. 863–8.
- Mura T, Picaud J-C, Larroque B, Galtier F, Marret S, Roze J-C, et al. Cognitive impairment at age 5 years in very preterm infants born following premature rupture of membranes. J Pediatr. 2013 Aug;163(2):435–40.e2.
- Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of the membranes: a systematic review. Obstet Gynecol. 2004 Nov;104(5, Part 1):1051–7.
- Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2010;(8):CD001058.
- Resources UDOHH. Antenatal Corticosteroids Revisited: Repeat Courses. National Institutes of Health Consunsus Statement Online. 2000 Jul 20;17(2):1–10.
- Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol. 1999;94(5, Part 2):869–77.
- Crowley P. Prophylactic corticosteroids for preterm birth. In: Crowley P, ed. Cochrane Database Systematic Review. Chichester, UK: Wiley; 1996 Sep 1 (2):1–32.
- Iams JD, Casal D, McGregor JA, Goodwin TM, Kreaden US, Lowensohn R, et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol. 1995 Jul;173(1):141–5.
- Rozenberg P, Goffinet F, Malagrida L, Giudicelli Y, Perdu M, Houssin I, et al. Evaluating the risk of preterm delivery: a comparison of fetal fibronectin and transvaginal ultrasonographic measurement of cervical length. Am J Obstet Gynecol. 1997 Jan;176(1 Pt 1):196–9.
- Sotiriadis A, Papatheodorou S, Kavvadias A, Makrydimas G. Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta-analysis. Ultrasound Obstet Gynecol. 2010 Jan;35(1):54–64.
- Berghella V, Hayes E, Visintine J, Baxter JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev. 2008;(4):1–23.
- Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325(10):669–74.
- van Baaren G-J, Vis JY, Grobman WA, Bossuyt PM, Opmeer BC, Mol BW. Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor. Am J Obstet Gynecol. 2013 Jun;209: 436.e1-436.e8.
- World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th ed. Geneva, Switzerland: WHO; 1993.
- Fisk NM, Chan J. The case for tocolysis in threatened preterm labour. BJOG. 2003 Apr;110(s20):98–102.
- Mackeen AD, Seibel-Seamon J, Grimes-Dennis J, Baxter JK, Berghella V. Tocolytics for preterm premature rupture of membranes. In: Mackeen AD, ed. Cochrane Database Systematic Review. Wiley; 1996 Sep 1.
- Di Renzo GC, Roura LC. Guidelines for the management of spontaneous preterm labor. J Perinatal Med. 2006;34(5):359–66.
- American College of Obstetricians and Gynecologists, Committee on Practice Bulletins –Obstetrics. ACOG practice bulletin no. 127: Management of preterm labor. Obstet Gynecol. 2012; 1308–17.
- Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, et al. The preterm prediction study: significance of vaginal infections. Am J Obstet Gynecol. 1995;173(4):1231–5.
- Kashanian M, Bahasadri S, Zolali B. Comparison of the efficacy and adverse effects of nifedipine and indomethacin for the treatment of preterm labor. Int J Gynecol Obstet. 2011 Jun;113(3):192–5.
- French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol. 2001 Oct;98(2):177–85.